Identification of a DMBT1 polymorphism associated with increased breast cancer 
risk and decreased promoter activity.

Tchatchou, S.; Riedel, A.; Lyer, S.; Schmutzhard, J.; Strobel-Freidekind, O.; Gronert-Sum, S.; Mietag, C.; D'Amato, M.; Schlehe, B.; Hemminki, K.; Sutter, C.; Ditsch, N.; Blackburn, A.; Hill, L. Z.; Jerry, D. J.; Bugert, P.; Weber, B. H.; Niederacher, D.; Arnold, N.; Varon-Mateeva, R.; Wappenschmidt, B.; Schmutzler, R. K.; Engel, C.; Meindl, A.; Bartram, C. R.; Mollenhauer, J.; Burwinkel, B.

doi:10.1002/humu.21134

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity.

MPS-Authors

Varon-Mateeva, R.
Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Tchatchou, S., Riedel, A., Lyer, S., Schmutzhard, J., Strobel-Freidekind, O., Gronert-Sum, S., Mietag, C., D'Amato, M., Schlehe, B., Hemminki, K., Sutter, C., Ditsch, N., Blackburn, A., Hill, L. Z., Jerry, D. J., Bugert, P., Weber, B. H., Niederacher, D., Arnold, N., Varon-Mateeva, R., Wappenschmidt, B., Schmutzler, R. K., Engel, C., Meindl, A., Bartram, C. R., Mollenhauer, J., & Burwinkel, B. (2010). Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. Human Mutations, 31(1), 60-66. doi:10.1002/humu.21134.

引用: https://hdl.handle.net/11858/00-001M-0000-0010-7C37-5

要旨

According to present estimations, the unfavorable combination of alleles with low penetrance but high prevalence in the population might account for the major part of hereditary breast cancer risk. Deleted in Malignant Brain Tumors 1 (DMBT1) has been proposed as a tumor suppressor for breast cancer and other cancer types. Genomewide mapping in mice further identified Dmbt1 as a potential modulator of breast cancer risk. Here, we report the association of two frequent and linked single-nucleotide polymorphisms (SNPs) with increased breast cancer risk in women above the age of 60 years: DMBT1 c.-93C>T, rs2981745, located in the DMBT1 promoter; and DMBT1 c.124A>C, p.Thr42Pro, rs11523871(odds ratio [OR]=1.66, 95% confidence interval [CI]=1.21-2.29, P=0.0017; and OR=1.66; 95% CI=1.21-2.28, P=0.0016, respectively), based on 1,195 BRCA1/2 mutation-negative German breast cancer families and 1,466 unrelated German controls. Promoter studies in breast cancer cells demonstrate that the risk-increasing DMBT1 -93T allele displays significantly decreased promoter activity compared to the DMBT1 -93C allele, resulting in a loss of promoter activity. The data suggest that DMBT1 polymorphisms in the 5'-region are associated with increased breast cancer risk. In accordance with previous results, these data link decreased DMBT1 levels to breast cancer risk.